1.Clevers H: The cancer stem cell: premises, promises and challenges. Nature medicine 2011:313-319.
2.Visvader JE: Cells of origin in cancer. Nature 2011, 469(7330):314-322.
3.Deonarain MP, Kousparou CA, Epenetos AA: Antibodies targeting cancer stem cells: A new paradigm in immunotherapy? In: MAbs: 2009: Landes Bioscience; 2009: 12-25.
4.Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature medicine 1997, 3(7):730-737.
5.Baumann U, Crosby HA, Ramani P, Kelly DA, Strain AJ: Expression of the stem cell factor receptor c‐kit in normal and diseased pediatric liver: Identification of a human hepatic progenitor cell? Hepatology 2003, 30(1):112-117.
6.Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences 2003, 100(7):3983-3988.
7.Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer research 2005, 65(23):10946-10951.
8.Kondo T, Ezzat S, Asa SL: Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nature Reviews Cancer 2006, 6(4):292-306.
9.Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V, Yamashita S: Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 2007, 148(4):1797-1803.
10.Lin RY: Thyroid cancer stem cells. Nature Reviews Endocrinology 2011, 7(10):609-616.
11.Zito G, Richiusa P, Bommarito A, Carissimi E, Russo L, Coppola A, Zerilli M, Rodolico V, Criscimanna A, Amato M: In vitro identification and characterization of CD133pos cancer stem-like cells in anaplastic thyroid carcinoma cell lines. PloS one 2008, 3(10):e3544.
12.Friedman S, Lu M, Schultz A, Thomas D, Lin RY: CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. PloS one 2009, 4(4):e5395.
13.Ke CC, Liu RS, Yang AH, Liu CS, Chi CW, Tseng LM, Tsai YF, Ho JH, Lee CH, Lee OK: CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy. European Journal of Nuclear Medicine and Molecular Imaging 2012:1-11.
14.Tseng LM, Huang PI, Chen YR, Chen YC, Chou YC, Chen YW, Chang YL, Hsu HS, Lan YT, Chen KH: Targeting Signal Transducer and Activator of Transcription 3 Pathway by Cucurbitacin I Diminishes Self-Renewing and Radiochemoresistant Abilities in Thyroid Cancer-Derived CD133+ Cells. Journal of Pharmacology and Experimental Therapeutics 2012, 341(2):410-423.
15.Zhu W, Hai T, Ye L, Cote GJ: Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity. Journal of Clinical Endocrinology & Metabolism 2010, 95(1):439-444.
16.Todaro M, Iovino F, Eterno V, Cammareri P, Gambara G, Espina V, Gulotta G, Dieli F, Giordano S, De Maria R: Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer research 2010, 70(21):8874-8885.
17.Malaguarnera R, Frasca F, Garozzo A, Gianì F, Pandini G, Vella V, Vigneri R, Belfiore A: Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. Journal of Clinical Endocrinology & Metabolism 2011, 96(3):766-774.
18.Derwahl M: Linking stem cells to thyroid cancer. Journal of Clinical Endocrinology & Metabolism 2011, 96(3):610-613.
19.Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. 2001.
20.Zheng X, Cui D, Xu S, Brabant G, Derwahl M: Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. International journal of oncology 2010, 37(2):307.
21.Chen G, Xu S, Renko K, Derwahl M: Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents. Journal of Clinical Endocrinology & Metabolism 2012, 97(4):E510-E520.